A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia .

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of the study is to explore the optimal dose and administration of the experimental drug, and to evaluate the safety and efficacy of the drug in patients with renal anemia. Patients with renal anemia on regular dialysis treatment are expected to be enrolled in this study.
Epistemonikos ID: b95d893f464b53ecebf22eb72502115533222dc1
First added on: May 14, 2024